Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

Kit/SCF signaling and Mitf-dependent transcription are both essential for melanocyte development and pigmentation. To identify Mitf-dependent Kit transcriptional targets in primary melanocytes, microarray studies were undertaken. Among identified targets was BCL2, whose germline deletion produces melanocyte loss and which exhibited phenotypic synergy with Mitf in mice. BCL2's regulation by Mitf was verified in melanocytes and melanoma cells and by chromatin immunoprecipitation of the BCL2 promoter. Mitf also regulates BCL2 in osteoclasts, and both Mitf(mi/mi) and Bcl2(-/-) mice exhibit severe osteopetrosis. Disruption of Mitf in melanocytes or melanoma triggered profound apoptosis susceptible to rescue by BCL2 overexpression. Clinically, primary human melanoma expression microarrays revealed tight nearest neighbor linkage for MITF and BCL2. This linkage helps explain the vital roles of both Mitf and Bcl2 in the melanocyte lineage and the well-known treatment resistance of melanoma.

[1]  X. Liu,et al.  A gene for Waardenburg Syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12–p14.1 , 1994, Nature Genetics.

[2]  Y. Kitamura,et al.  Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice. , 2001, Blood.

[3]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Nguyen,et al.  Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently , 1998, Mechanisms of Development.

[5]  E. Price,et al.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. , 2000, Genes & development.

[6]  A. Folpe,et al.  Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. , 2001, Advances in anatomic pathology.

[7]  S. Nishikawa,et al.  Dominant role of the niche in melanocyte stem-cell fate determination , 2002, Nature.

[8]  L. From,et al.  bcl-2 protein expression in melanocytic neoplasms of the skin. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  S. Korsmeyer,et al.  Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.

[10]  E. Johnson,et al.  Nerve Growth Factor Induces the Expression of Certain Cytokine Genes and bcl-2 in Mast Cells , 1996, The Journal of Biological Chemistry.

[11]  I. Weissman,et al.  Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice , 1997, Cell.

[12]  H. Pehamberger,et al.  Chemosensitisation of malignant melanoma by BCL2 antisense therapy , 2000, The Lancet.

[13]  D. Fisher,et al.  Microphthalmia transcription factor , 2001, Cancer.

[14]  E. Russell.  Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.

[15]  G. Wilson,et al.  Bcl-2 expression in malignant melanoma and its prognostic significance. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  E. Price,et al.  MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes , 1998, Nature.

[17]  A. Ferré-D’Amaré,et al.  Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences , 1994, Nature Genetics.

[18]  D. Fisher,et al.  Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes , 1998, The Journal of cell biology.

[19]  K. Luo,et al.  SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. , 1997, Genes & development.

[20]  D. Fisher,et al.  Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3 , 1998, The Journal of experimental medicine.

[21]  M. Ichihashi,et al.  Accelerated disappearance of melanocytes in bcl-2-deficient mice. , 1996, Cancer research.

[22]  E. Yeh,et al.  Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. , 2000, Experimental cell research.

[23]  M. Al‐Rubeai,et al.  The Bcl-2 Family , 2004 .

[24]  M. Mihm,et al.  Microphthalmia Transcription Factor Expression in Cutaneous Benign, Malignant Melanocytic, and Nonmelanocytic Tumors , 2001, The American journal of surgical pathology.

[25]  John C Reed,et al.  Bcl-2 family proteins , 1998, Oncogene.

[26]  R. Boissy,et al.  A mouse model for vitiligo. , 1986, The Journal of investigative dermatology.

[27]  K. Franssila,et al.  Microphthalmia Transcription Factor in the Immunohistochemical Diagnosis of Metastatic Melanoma: Comparison With Four Other Melanoma Markers , 2001, The American journal of surgical pathology.

[28]  D. Fisher,et al.  Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Levi‐montalcini,et al.  Nerve growth factor. , 1975, Science.

[30]  Matthew G. Vander Heiden,et al.  Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? , 1999, Nature Cell Biology.

[31]  D. McConkey,et al.  CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells* , 1998, The Journal of Biological Chemistry.

[32]  D. Loh,et al.  Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Mihm,et al.  Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. , 1999, The American journal of pathology.

[34]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Hunter,et al.  Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility , 2000, Nature Genetics.

[36]  D. Fisher,et al.  Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. , 2001, Molecular cell.

[37]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[38]  G. Demetri,et al.  Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo , 1996, The Journal of experimental medicine.

[39]  K. Heidenreich,et al.  Insulin-like Growth Factor-I Induces bcl-2 Promoter through the Transcription Factor cAMP-Response Element-binding Protein* , 1999, The Journal of Biological Chemistry.

[40]  P. Duray,et al.  Human melanocytes cultured from nevi and melanomas. , 1986, The Journal of investigative dermatology.

[41]  T. Noda,et al.  bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. , 1995, Cancer research.

[42]  D. Banerjee.  Genasense (Genta Inc). , 2001, Current opinion in investigational drugs.

[43]  E. Price,et al.  Sensorineural Deafness and Pigmentation Genes Melanocytes and the Mitf Transcriptional Network , 2001, Neuron.

[44]  H. Kerl,et al.  bcl‐2 Protein Expression in Cutaneous Malignant Melanoma and Benign Melanocytic Nevi , 1995, The American Journal of dermatopathology.

[45]  A. Folpe,et al.  Microphthalmia Transcription Factor and Melanoma Cell Adhesion Molecule Expression Distinguish Desmoplastic/Spindle Cell Melanoma From Morphologic Mimics , 2001, The American journal of surgical pathology.

[46]  M. Caligiuri,et al.  The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Goding,et al.  Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. , 2000, Genes & development.

[48]  K. J. Moore.  Insight into the microphthalmia gene. , 1995, Trends in genetics : TIG.

[49]  O. Witte.  Steel locus defines new multipotent growth factor , 1990, Cell.

[50]  M. Eisinger,et al.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Andrew P. Read,et al.  Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene , 1994, Nature Genetics.

[52]  James A. Vaught,et al.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. , 1994, Genes & development.

[53]  M. Donath,et al.  Insulin-Like Growth Factor I , 1999, Drugs & aging.

[54]  C. Goding,et al.  The Gene Encoding the T-box Factor Tbx2 Is a Target for the Microphthalmia-associated Transcription Factor in Melanocytes* , 2000, The Journal of Biological Chemistry.

[55]  S. Bhattacharya,et al.  Lineage-specific Signaling in Melanocytes , 1998, The Journal of Biological Chemistry.

[56]  I. Jackson,et al.  Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. , 1997, Developmental biology.

[57]  D. Metcalfe,et al.  Human Mast Cell Apoptosis Is Regulated Through Bcl-2 and Bcl-XL , 2001, Journal of Clinical Immunology.

[58]  H. Pehamberger,et al.  Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines , 1998, Melanoma research.

[59]  K. Heidenreich,et al.  Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding Protein* , 2000, The Journal of Biological Chemistry.